Skip to main content

Table 1 Characteristics of subjects with and without diabetes

From: Do patients with type 1 and type 2 diabetes really have an impaired endothelial function? A population-based propensity score matching analysis

 

SHIP-population

 

Outpatients

 

Non diabetic

Type 2 diabetes

Type 1 diabetes

 

n = 1365

n = 122

n =65

Age, yr

51 (25–85)

63 (31–84)

50 (23–75)

Sex (male)

679 (49.7%)

68 (55.7%)

31 (47.7%)

Smoking status

 

 

Never-smoker

590 (43.3%)

48 (39.3%)

32 (49.2%)

Ex-smoker

427 (31.3%)

61 (50.0%)

14 (21.5%)

Current smoker

347 (25.4%)

13 (10.7%)

19 (29.2%)

Body mass index, kg/m2

27.0 (16.8–49.8)

31.0 (19.8–50.0)

26.5 (20.0–41.5)

Waist circumference, cm

91.3 (57.3–155.0)

103.0 (75.2–135.0)

91.2 (63.0–126.1)

Systolic blood pressure, mmHg

129 (89–219)

135 (90–208)

137 (101–179)

Diastolic blood pressure, mmHg

82 (54–122)

79 (57–113)

78 (47–101)*

Hypertension

623 (45.7%)

92 (75.4%)

41 (63.1)

Use of antihypertensive medication

418 (30.6%)

98 (80.3%)

37 (56.9%)

HDL cholesterol, mmol/l

1.13 (0.39–2.82)

0.87 (0.42–2.22)

1.35 (0.53–2.84)

LDL cholesterol, mmol/l

3.46 (0.73–11.03)

3.19 (1.45–5.99)*

2.98 (1.64–5.06)

Triglycerides, mmol/l

1.43 (0.17–52.22)

1.99 (0.32–13.27)

1.04 (0.31–4.74)

Use of sex hormones medication

126 (9.2%)

1 (0.8%)

2 (3.1%)

Glucose, mmol/l

5.1 (3.3–11.1)

6.4 (2.4–20.2)

8.4 (1.5–22.8)

HbA1c,%

5.2 (2.8–6.4)

6.5 (3.7–10.1)

7.5 (4.3–11.7)

Albumin, mg/l

5.4 (0–2120)

10.6 (0–2880)

12.6 (2.4–756)

Baseline diameter A.brachialis, mm

3.84 (2.10–6.01)

4.07 (2.21–6.01)

3.78 (2.54–4.99)*

FMD,%

4.51 (-8.44–29.41)

3.89 (-3.50–11.13)*

4.21 (-1.32–14.79)

  1. Data are given as number (percentage) or median (minimum-maximum).
  2. *p < 0.05, p < 0.01, p < 0.001 c2-test (nominal data) or Mann-Whitney U test (continuous data).
  3. Comparisons were performed separately against non-diabetics.
  4. HDL, high-density-lipoprotein; LDL, low-density-lipoprotein; HbA1c, hemoglobin A1c; FMD, flow-mediated dilatation.